OPKO Health Appoints Dr. Roger Medel to its Board of Directors
December 21 2020 - 08:00AM
OPKO Health, Inc. (NASDAQ: OPK) today announced
the appointment of Roger Medel, M.D. as an independent member of
its Board of Directors, effective December 18, 2020. With this
appointment, the OPKO Health Board has 11 Directors, including
seven independent Directors.
“We are delighted to welcome Roger to the OPKO
Health Board of Directors,” stated Dr. Phillip Frost, Chairman and
Chief Executive Officer of OPKO Health. “Roger brings a unique
perspective based on his vast experience as a physician and as an
executive growing a successful healthcare services organization. We
look forward to Roger’s valuable insight and deep knowledge as we
continue to execute OPKO’s strategy.”
Dr. Medel is the co-founder of MEDNAX, Inc., a
national health solutions partner comprised of the nation’s leading
providers of physician services, and has served as a Director of
MEDNAX since 1979. In addition, he served as MEDNAX’s President
from its founding until May 2000, then again from March 2003 until
May 2004, and as its Chief Executive Officer since its founding
until December 2002 then again from March 2003 until his retirement
in July 2020. Under his leadership, the company grew from one small
group of neonatologists managing care in one local hospital, to a
group of more than 1,200 neonatologists and more than 1,000
advanced practice nurses that manages neonatology departments,
including neonatal intensive care units in approximately 400
hospitals. Additionally, MEDNAX expanded into the largest group of
pediatric cardiologists, pediatric intensivists and maternal fetal
specialists. The company currently cares for approximately 25% of
the sick and premature babies born annually in the United
States.
Dr. Medel has served as a member of the Board of
Trustees of the Dana Farber Cancer Institute, Inc. since January
2016. In addition, he was a member of the Board of Trustees of the
University of Miami from January 2004 to February 2012, and from
June 2006 to April 2009 served on the Board of Directors of MBF
Healthcare Acquisition Corp. Dr. Medel actively participates as a
member of several medical and professional organizations.
About OPKO Health
OPKO is a multinational biopharmaceutical and
diagnostics company that seeks to establish industry-leading
positions in large, rapidly growing markets by leveraging its
discovery, development, and commercialization expertise and novel
and proprietary technologies. For more information, visit
www.opko.com.
Contacts:
LHA Investor RelationsYvonne
Briggs, 310-691-7100ybriggs@lhai.comorBruce Voss, 310-691-7100
bvoss@lhai.com
Opko Health (NASDAQ:OPK)
Historical Stock Chart
From Feb 2024 to Mar 2024
Opko Health (NASDAQ:OPK)
Historical Stock Chart
From Mar 2023 to Mar 2024